Alphabet life sciences arm to invest in EU drug development
Verily and Novartis back new $300m Medicxi fund that will focus on biotech groups
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Pharmaceuticals